Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Mycronic AB ( (SE:MYCR) ) is now available.
Mycronic AB reported a 35% increase in net sales for the second quarter of 2025, driven by strong growth in Pattern Generators, High Volume, and Global Technologies, despite a 37% decline in order intake. The company completed acquisitions of RoBAT and Surfx Technologies, enhancing its capabilities in PCB testing and surface treatment solutions. The outlook for 2025 has been revised upward, reflecting confidence in achieving higher net sales, supported by a strong performance in the Chinese market and strategic expansions.
More about Mycronic AB
Mycronic AB operates in the electronics manufacturing industry, specializing in advanced production equipment and solutions for PCB assemblies, photomask markets for displays and semiconductors, and surface treatment technologies. The company is focused on expanding its market presence through strategic acquisitions and enhancing its product offerings across various business lines, including PCB Test, Die Bonding, and Applied Plasma.
Average Trading Volume: 226,733
Current Market Cap: SEK39.71B
Learn more about MYCR stock on TipRanks’ Stock Analysis page.